NIMR Signs Strategic Teaming Agreement With Saudi Arabian Military Industries (SAMI)
NIMR, the leading manufacturer of combat-proven wheeled military vehicles, today signed a Teaming Agreement with Saudi Arabian Military Industries (SAMI), a wholly owned subsidiary of the Public Investment Fund, to establish a framework for future collaboration to explore opportunities for the JAIS 4x4 vehicle in Saudi Arabia. The deal was inked at the International Defence Exhibition and Conference (IDEX 2021) event.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210222005790/en/
His Excellency Staff Major General Pilot Faris Khalaf Al Mazrouei, Chairman of the NIMR Board and Eng. Walid Abukhaled, CEO of SAMI, signed the agreement in the presence of His Excellency Eng. Ahmed A. Alohali, Governor of the General Authorities for Military Industries (GAMI), His Excellency Turki bin Abdullah Al-Dakhil, Ambassador of the Custodian of the Two Holy Mosques to the UAE, His Excellency Faisal Al Bannai, CEO and Managing Director of EDGE, and other leading representatives from NIMR and SAMI. (Photo: AETOSWire)
His Excellency Staff Major General Pilot Faris Khalaf Al Mazrouei, Chairman of the NIMR Board and Eng. Walid Abukhaled, CEO of SAMI, signed the agreement in the presence of His Excellency Eng. Ahmed A. Alohali, Governor of the General Authorities for Military Industries (GAMI), His Excellency Turki bin Abdullah Al-Dakhil, Ambassador of the Custodian of the Two Holy Mosques to the UAE, His Excellency Faisal Al Bannai, CEO and Managing Director of EDGE, and other leading representatives of the two entities.
NIMR and SAMI have been negotiating the terms of a potential partnership – the Teaming Agreement encapsulates this outcome. Designed to lay the foundation for a long-term joint venture between the two entities, the agreement mandates NIMR to license technology to the Kingdom to enable local manufacture of the JAIS vehicle and develop Saudi Arabia’s supply chain capabilities. The synergy aligns seamlessly with the Saudi Vision 2030 that underlines the country’s commitment to reaching the goal of localising industry and diversifying the economy.
The JAIS 4x4 competed against a range of vehicles in demanding trials arranged by SAMI and conducted by military experts in Saudi Arabia. The exceptional performance of the battle-tested platform in the trials paved the way for new opportunities for the vehicle in Saudi Arabia.
Speaking on the occasion, His Excellency Faisal Al Bannai, CEO and Managing Director of EDGE, said: “Fostering strategic relationships is a key pillar of EDGE’s strategy, and we look forward to building on this commitment with our colleagues at SAMI. This agreement represents the first military collaboration between Saudi Arabia and the UAE and is a major step in boosting the already robust relations between our respective nations.”
Eng. Walid Abukhaled, CEO of SAMI, said: “We are pleased to witness the culmination of our shared efforts over the past year as we ink this agreement to transfer technology and knowledge to Saudi Arabia’s defence manufacturing sector, contributing to the Saudi Vision 2030 objective of localizing over 50 percent of the military equipment spending by 2030. This achievement also supports PIF’s efforts through SAMI in localizing cutting-edge technology and knowledge, as well as building strategic economic partnerships.”
NIMR is part of the Platforms & Systems cluster within EDGE, an advanced technology group for defence and beyond that ranks among the top 25 military suppliers in the world.
About EDGE
EDGE is an advanced technology group established to develop agile, bold and disruptive solutions for defence and beyond. Enabling a secure future, it is dedicated to bringing innovative technologies and services to market with greater speed and efficiency. Consolidating over 25 entities and employing more than 13,000 brilliant minds, it offers expertise across five core clusters: Platforms & Systems, Missiles & Weapons, Cyber Defence, Electronic Warfare & Intelligence and Mission Support. Headquartered in Abu Dhabi, United Arab Emirates, EDGE is a catalyst for change – set to revolutionise the industry and change its fundamentals.
For more information, visit edgegroup.ae
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210222005790/en/
Contact information
EDGE Group Press Office
Thushara Mohanan, media@edgegroup.ae
+971555080413
+971553584520
About Business Wire
Business WireSubscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 02:09:00 CEST | Press release
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio har
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release
HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom